Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize olanzapine pharmacokinetics: the inter- and
intra- subject variabilities of olanzapine pharmacokinetics; and the potential influence of
patient factors such as age, weight, gender, origin, and smoking status on olanzapine
pharmacokinetics in adolescents with schizophrenia or bipolar I disorder. This study will
also assess the safety of olanzapine delivered orally.